Clinical Trials
2 trialsNCT06613100 2026-05-14
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
Amgen
Phase 1 Recruiting
NCT06528210 2025-09-23
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer
OHSU Knight Cancer Institute
Phase 2 Withdrawn